BCL2L1 and neoplasm: When grouping B2 and B3 TH and TC according to MCL-1 and BCL-xL expression (Fig. 1G), we found a significantly decreased tumor survival in patients with high expression of both MCL-1 and BCL-xL (Fig. 1H).